Ubs Group Ag Covetrus, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$20.69 - $20.91 $43.4 Million - $43.9 Million
2,097,309 Added 246.14%
2,949,382 $61.6 Million
Q2 2022

Aug 10, 2022
BUY
$13.8 - $20.82 $11.3 Million - $17.1 Million
820,155 Added 2569.57%
852,073 $17.7 Million
Q1 2022

May 16, 2022
SELL
$15.96 - $18.87 $319,279 - $377,494
-20,005 Reduced 38.53%
31,918 $536,000
Q4 2021

Feb 14, 2022
SELL
$16.79 - $20.37 $621,834 - $754,423
-37,036 Reduced 41.63%
51,923 $1.04 Million
Q3 2021

Nov 15, 2021
SELL
$18.14 - $27.03 $844,888 - $1.26 Million
-46,576 Reduced 34.36%
88,959 $1.61 Million
Q2 2021

Aug 13, 2021
BUY
$25.24 - $30.86 $867,675 - $1.06 Million
34,377 Added 33.98%
135,535 $3.66 Million
Q1 2021

May 12, 2021
SELL
$28.29 - $39.89 $870,313 - $1.23 Million
-30,764 Reduced 23.32%
101,158 $3.03 Million
Q4 2020

Feb 11, 2021
BUY
$24.45 - $31.59 $52,396 - $67,697
2,143 Added 1.65%
131,922 $3.79 Million
Q3 2020

Nov 12, 2020
BUY
$17.22 - $24.59 $78,592 - $112,228
4,564 Added 3.64%
129,779 $3.17 Million
Q2 2020

Jul 31, 2020
BUY
$6.46 - $19.27 $745,077 - $2.22 Million
115,337 Added 1167.61%
125,215 $2.24 Million
Q1 2020

May 01, 2020
SELL
$5.64 - $15.23 $104,464 - $282,090
-18,522 Reduced 65.22%
9,878 $80,000
Q4 2019

Feb 14, 2020
SELL
$8.8 - $14.93 $143,589 - $243,612
-16,317 Reduced 36.49%
28,400 $375,000
Q3 2019

Nov 14, 2019
BUY
$11.76 - $25.57 $233,976 - $508,740
19,896 Added 80.16%
44,717 $531,000
Q2 2019

Aug 14, 2019
SELL
$22.88 - $33.27 $170,387 - $247,761
-7,447 Reduced 23.08%
24,821 $606,000
Q1 2019

May 14, 2019
BUY
$31.52 - $46.19 $1.02 Million - $1.49 Million
32,268 New
32,268 $1.03 Million

Others Institutions Holding CVET

# of Institutions
8
Shares Held
72.9K
Call Options Held
0
Put Options Held
0
View Full List

About COVETRUS, INC.

CVET Quotes by TradingView
  • Ticker CVET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 140,123,008
  • Description
  • Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...
More about CVET
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email